Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-05-02
2000-09-12
Stucker, Jeffrey
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 79, 435 792, 435 691, 435975, 4241861, 4242181, 436536, 530350, 536 234, 536 2372, A61K 3912, C07H 2104, C07K 1418
Patent
active
061176400
ABSTRACT:
A recombinant protein encompassing a C-terminal protion from the structural envelope glycoprotein and an N-terminal portion from non-structural protein one of dengue type 2 virus was expressed in Escherichia coli as a fusion protein with Staphylococcal protein A. The recombinant protein was found to provide protection against lethal challenge with dengue 2 in mice.
REFERENCES:
Srivastava, A. K. et al. Japanese encephalitis virus fusion protein with tein A expressed in Escherichia coli confers protective immunity in mice. Microbiol. Immunol., 1991, 35: 863-870.
Srivastava, A. K. et al. Mice immunized with dengue-2 virus E and NS-1 fusion protein are protected against lethal dengue virus infection. Abstract, 43rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Sep. 1994, 51:437.
Ulmer, J. B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science, 1993, 259: 1745-1749.
Acsadi, G. et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature, 1991, 352: 815-818.
Wolff, J. A. et al. Direct gene transfer into mouse muscle in vivo. Science, 1990, 247:1465-1468.
Zhang et al. J. Virol., 62(8), Aug. 1988, p. 3027-3031.
Mason et al. J. Gen. Virol., vol. 71, 1990, p 2107-2114.
Parrish et al. Arch. Virol., vol. 117, 1991, p 279-286.
Fonseca et al. Vaccine, 12(3), 1994, p 279-285.
Feighny et al. Amer. J. Trop. Med. and Hygiene. 50(3), 1994, p 322-328, Abstract.
Eckels et al. Amer. J. Trop. Med. and Hygiene.50(4). 1994, p 472-478.
Hoke Charles H.
Putnak J. Robert
Srivastava Ashok Kumar
Warren Richard L.
Bui Phuong T
Harris Charles H.
Moran John Francis
Stucker Jeffrey
The United States of America as represented by the Secretary of
LandOfFree
Recombinant vaccine made in E. coli against dengue virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccine made in E. coli against dengue virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccine made in E. coli against dengue virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-94482